8-K
File 000-22873
8-K
- Filing date
- 31 Jul 2018
- Reporting date
- 31 Jul 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
Oruka Therapeutics, Inc. reports
- Company location
- Menlo Park, CA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
Oruka Therapeutics, Inc. has filed 1,498 SEC EDGAR filings since 12 Jun 1997
SEC filing history
Showing 426-450 of 936 matching filings.
Per page
25
Current page
18
8-K
File 000-22873
8-K
- Filing date
- 05 Jun 2018
- Reporting date
- 31 May 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-22873
8-K
- Filing date
- 29 May 2018
- Reporting date
- 27 May 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
CT ORDER
File 000-22873
CT ORDER filing
- Filing date
- 10 May 2018
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-22873
8-K
- Filing date
- 08 May 2018
- Reporting date
- 08 May 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-22873
10-Q
- Filing date
- 08 May 2018
- Reporting date
- 31 Mar 2018
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-22873
8-K
- Filing date
- 23 Apr 2018
- Reporting date
- 17 Apr 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
DEFA14A
File 000-22873
DEFA14A
- Filing date
- 18 Apr 2018
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
DEF 14A
File 000-22873
DEF 14A
- Filing date
- 18 Apr 2018
- Reporting date
- 31 May 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-22873
8-K
- Filing date
- 16 Apr 2018
- Reporting date
- 11 Apr 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 03 Apr 2018
- Reporting date
- 03 Apr 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 03 Apr 2018
- Reporting date
- 02 Apr 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-22873
8-K
- Filing date
- 22 Mar 2018
- Reporting date
- 22 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-K
File 000-22873
10-K
- Filing date
- 22 Mar 2018
- Reporting date
- 31 Dec 2017
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
SC 13G/A
File 005-51477
SC 13G/A filing
- Filing date
- 08 Mar 2018
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 05 Mar 2018
- Reporting date
- 01 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 05 Mar 2018
- Reporting date
- 01 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 05 Mar 2018
- Reporting date
- 01 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 05 Mar 2018
- Reporting date
- 01 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 05 Mar 2018
- Reporting date
- 01 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-22873
8-K
- Filing date
- 05 Mar 2018
- Reporting date
- 01 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D/A
File 005-51477
GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- ARCA BIOPHARMA, INC. - SCHEDULE 13D
- Filing date
- 05 Mar 2018
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 01 Mar 2018
- Reporting date
- 28 Feb 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
FORM 4 SUBMISSION
- Filing date
- 01 Mar 2018
- Reporting date
- 27 Feb 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 28 Feb 2018
- Reporting date
- 26 Feb 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing